| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0004 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |